TTY Biopharm Co., Ltd. manufactures and markets various kinds of medicines. The company's products encompass a variety of therapeutic segments, including cardiology, gastroenterology, orthopedics and cancer.

The Company Was Invited By Yuanta Securities To
Participate The On-Line Investors' Conference

Announcement Of Tty Biopharm'S Unaudited Income
Information In October 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tty Biopharm (4105 TT)

The Company Was Invited By Yuanta Securities To Participate The On-Line Investors' Conference

Announcement Of Tty Biopharm'S Unaudited Income Information In October 2025

Announcement Of The Consolidated Financial Report For The Third Quarter Of Year 2025

Announcement For The Expected Date Of The Board Of Directors Meeting For 2025 3rd Quarter Financial Statements Is 2025/11/06

Correction On Announcement Of Tty Biopharm'S Unaudited Income Information In September 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)